CORTEX PHARMACEUTICALS, INC.
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 21, 2010 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 211 Total Citation Count
- Jun 24, 1993 Earliest Filing
- 7 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2010/0267,728 3-SUBSTITUTED-1,2,3-TRIAZIN-4-ONE'S AND 3 SUBSTITUTED 1,3-PYRIMIDINONE'S FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSESAbandonedSep 19, 08Oct 21, 10[A61K, C07D, A61P]
7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responsesExpiredNov 25, 02Sep 21, 10[A61K, C07D, A61P]
2010/0041,647 3-Substituted-[1,2,3]-Benzotriazinone compounds for enhancing glutamatergic synaptic responsesAbandonedDec 28, 07Feb 18, 10[A61K, C07D, A61P]
2006/0276,462 Method of treating cognitive decline due to sleep deprivation and stressAbandonedJan 13, 04Dec 07, 06[A61K, C07D]
2005/0228,019 Enhancement of ampakine-Induced facilitation of synaptic responses by cholinesterase inhibitorsAbandonedJan 26, 05Oct 13, 05[A61K]
5622981 Use of metabotropic receptor agonists in progressive neurodegenerative diseasesExpiredApr 07, 95Apr 22, 97[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
